Euthanasia: Autonomy, Risk, and the Ethics of Dying

Framing the Debate: Definitions and Distinctions

Precise terminology matters enormously in this debate. Voluntary euthanasia refers to a competent patient requesting that a physician actively end their life, typically by administering a lethal dose of medication. Physician-assisted suicide (PAS), sometimes called physician-assisted death, involves a physician prescribing a lethal medication that the patient self-administers. Involuntary and non-voluntary euthanasia — where the patient has not consented or cannot consent — are widely condemned and legally prohibited everywhere; they are distinct from the voluntary forms that lie at the heart of current policy debate. Most legal frameworks that have expanded access to assisted dying focus exclusively on voluntary, competent requests, often with specific safeguards such as waiting periods, multiple physician sign-offs, and documented prognosis of terminal illness. The Oregon Death with Dignity Act, passed by ballot measure in 1997, was the first such law in the United States and has become a primary reference point — positive and negative — for both supporters and critics worldwide.

The debate also runs through medicine's self-understanding. Physicians historically swore, in various formulations of the Hippocratic tradition, to "do no harm" — a phrase that different practitioners interpret in diametrically opposite ways when applied to dying patients. Whether hastening death upon request constitutes harm or relief is not a neutral medical fact but a values judgment, which is why national medical associations in different countries have reached different conclusions, and why individual physicians within the same system disagree.

The Case For: Autonomy, Dignity, and Compassion

The most philosophically powerful argument for legalizing voluntary euthanasia centers on individual autonomy — the principle that competent adults have the right to make fundamental decisions about their own lives and deaths. If personal sovereignty means anything, proponents argue, it must include the decision of when and how to die when facing irreversible suffering. The philosopher and bioethicist Peter Singer has long argued, from a utilitarian perspective, that what matters morally is the reduction of suffering; if a patient experiences their continued existence as a source of unrelenting pain with no prospect of recovery, then assisting in death can be the most compassionate available response. Singer's broader framework, developed across his work in applied ethics, insists that the quality of life — not merely its biological continuation — is the morally relevant consideration.

Empirical evidence from Oregon offers a frequently cited data point. Since the Death with Dignity Act took effect in 1997, the Oregon Health Authority has published annual reports documenting the use of the law. The data consistently show that the majority of patients who request lethal prescriptions cite loss of autonomy, decreasing ability to engage in enjoyable activities, and loss of dignity as primary concerns — not uncontrolled physical pain alone. Crucially, a notable proportion of patients who receive a prescription never use it; the availability of the option itself appears to provide psychological comfort. The law has processed thousands of prescriptions over more than two decades without the large-scale abuse that critics predicted, and there is no evidence from Oregon's data that economically disadvantaged patients have been disproportionately pressured into choosing death.

Supporters also point to international experience in the Netherlands and Belgium, both of which legalized euthanasia in 2002. Proponents note that palliative care and euthanasia are not mutually exclusive in Dutch and Belgian practice; patients typically engage extensively with palliative options before requesting euthanasia, and the legal frameworks require consultation with multiple physicians. The legal landscape in the United Kingdom shifted significantly in 2024 when the House of Commons passed, on its second reading, the Terminally Ill Adults (End of Life) Bill, marking a historic legislative milestone in a country that had long resisted such changes. For advocates, these developments across diverse legal and cultural contexts suggest that careful, regulated access to assisted dying can be implemented without collapsing into the worst-case scenarios opponents envision.

At the level of constitutional principle, the U.S. Supreme Court's 1997 decision in Washington v. Glucksberg rejected a claimed constitutional right to physician-assisted suicide but left the matter explicitly open for state legislatures to address — a ruling that, in the view of supporters, invited rather than foreclosed the legislative expansion of assisted dying at the state level. States including Washington (2008), Vermont (2013), California (2015), and Colorado (2016) subsequently passed their own Death with Dignity-style statutes, a steady legislative trend that proponents read as democratic societies gradually recognizing an individual right long overdue.

The Case Against: Protecting the Vulnerable and the Role of Medicine

Opponents of legalizing euthanasia marshal arguments that are no less serious, drawing on empirical concerns, medical ethics, and the sociology of vulnerable populations. The most pressing practical objection is the slippery slope — the claim, backed by observable data from certain jurisdictions, that once euthanasia is legalized for competent adults with terminal illness, the criteria inexorably expand. Critics point directly to Belgium and the Netherlands as cautionary examples. In Belgium, the law has been extended to include patients with psychiatric disorders and, since 2014, to minors — expansions that were not part of the original legislative compromise. In the Netherlands, the Groningen Protocol (2004) introduced a framework for euthanizing severely ill newborns under parental and medical consent, a development that critics regard as evidence that initial safeguards do not hold over time. For opponents, these are not hypothetical futures but documented trajectories.

The concern about vulnerable populations takes a structural rather than anecdotal form in the work of disability rights scholars and organizations. Groups such as Not Dead Yet have argued consistently that legalization creates social pressure — often subtle and systemic rather than overt — on elderly, disabled, and chronically ill people to choose death rather than be perceived as burdens on families and healthcare systems. The bioethicist Felicia Ackerman has raised the concern that a society's willingness to fund quality palliative and long-term care may diminish once assisted dying is available as a cheaper alternative; the "choice" to die, on this view, may be less freely made when the alternative — comprehensive, high-quality supportive care — is inadequately resourced. This structural critique argues that expanding patient options is not genuinely liberating unless all options are equally accessible.

Medical professional opposition rests on the argument that euthanasia fundamentally distorts the physician-patient relationship. The American Medical Association, in its long-standing position, has held that physician-assisted suicide is incompatible with the physician's role as healer. Critics drawing on palliative care medicine contend that advances in pain management, hospice care, and symptom control have made it possible to address the vast majority of end-of-life suffering without hastening death. Dame Cicely Saunders, who founded the modern hospice movement in the United Kingdom in the 1960s, argued that the proper response to suffering is neither to ignore it nor to eliminate the sufferer, but to provide comprehensive "total pain" management — physical, emotional, social, and spiritual. Many palliative care physicians today continue in this tradition, arguing that requests for euthanasia most often reflect undertreated depression or inadequately managed pain rather than a settled, autonomous desire to die.

Legal scholars and disability advocates also raise the diagnostic uncertainty problem: terminal prognoses are frequently inaccurate. Patients given six-month prognoses sometimes live for years. If access to assisted dying is conditioned on a terminal prognosis, the epistemological fragility of that prognosis means some patients may choose death who would have recovered or lived meaningfully longer than predicted. Critics contend that the irreversibility of death demands a higher standard of certainty than medicine can reliably provide.